FIM
Fernwood Investment Management Portfolio holdings
AUM
$288M
This Quarter Return
-19.14%
1 Year Return
+33.53%
3 Year Return
+83.32%
5 Year Return
+196.78%
10 Year Return
+650.37%
AUM
$157M
AUM Growth
+$157M
(-25%)
Cap. Flow
-$4.46M
Cap. Flow
% of AUM
-2.85%
Top 10 Holdings %
Top 10 Hldgs %
27.76%
Holding
169
New
10
Increased
44
Reduced
55
Closed
23
Top Buys
| 1 |
SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
|
$1.26M |
| 2 |
Bristol-Myers Squibb
BMY
|
$729K |
| 3 |
Health Care Select Sector SPDR Fund
XLV
|
$597K |
| 4 |
Ares Capital
ARCC
|
$587K |
| 5 |
First Trust US Equity Opportunities ETF
FPX
|
$560K |
Top Sells
| 1 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$2.71M |
| 2 |
Eli Lilly
LLY
|
$1.39M |
| 3 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
$411K |
| 4 |
CCXI
ChemoCentryx, Inc.
CCXI
|
$396K |
| 5 |
Biogen
BIIB
|
$386K |
Sector Composition
| 1 | Healthcare | 25.5% |
| 2 | Technology | 10.31% |
| 3 | Consumer Discretionary | 7.05% |
| 4 | Financials | 6.49% |
| 5 | Communication Services | 6.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
GBT
1
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $10.5M | 6.68% | 204,912 -53,100 | -21% | -$2.71M |
|
2
iShares Core S&P 500 ETF
IVV
$662B
| $5.09M | 3.25% | 19,710 +31 | +0.2% | +$8.01K |
|
3
Meta Platforms (Facebook)
META
$1.86T
| $4.13M | 2.64% | 24,758 -346 | -1% | -$57.7K |
|
4
Amazon
AMZN
$2.44T
| $3.84M | 2.45% | 1,968 +82 | +4% | +$160K |
|
5
MongoDB
MDB
$25.7B
| $3.51M | 2.24% | 25,712 +194 | +0.8% | +$26.5K |
|
|
MYOK
6
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $3.34M | 2.13% | 71,236 -8,772 | -11% | -$411K |
|
7
Visa
V
$683B
| $3.31M | 2.11% | 20,558 -76 | -0.4% | -$12.2K |
|
8
Vanguard Mega Cap Growth ETF
MGK
$28.9B
| $3.31M | 2.11% | 26,008 +2,307 | +10% | +$293K |
|
9
iShares US Consumer Staples ETF
IYK
$1.35B
| $3.24M | 2.07% | 29,973 +2,857 | +11% | +$309K |
|
10
Gilead Sciences
GILD
$140B
| $3.23M | 2.06% | 43,252 -1,308 | -3% | -$97.8K |
|
11
BridgeBio Pharma
BBIO
$9.89B
| $2.99M | 1.91% | 103,250 -1,150 | -1% | -$33.3K |
|
12
CVS Health
CVS
$92.8B
| $2.99M | 1.91% | 50,329 -244 | -0.5% | -$14.5K |
|
13
Altria Group
MO
$113B
| $2.85M | 1.82% | 73,666 -540 | -0.7% | -$20.9K |
|
14
Dayforce
DAY
$11B
| $2.61M | 1.67% | 52,140 +1,000 | +2% | +$50.1K |
|
15
Texas Pacific Land
TPL
$21.5B
| $2.6M | 1.66% | 6,830 +487 | +8% | +$185K |
|
16
Johnson & Johnson
JNJ
$427B
| $2.36M | 1.51% | 17,987 -108 | -0.6% | -$14.2K |
|
|
PTLA
17
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $2.32M | 1.48% | 325,645 -10,466 | -3% | -$74.6K |
|
18
Philip Morris
PM
$260B
| $2.27M | 1.45% | 31,098 -250 | -0.8% | -$18.2K |
|
19
Alphabet (Google) Class A
GOOGL
$2.57T
| $2.26M | 1.44% | 1,943 +5 | +0.3% | +$5.81K |
|
20
SBA Communications
SBAC
$22B
| $2.21M | 1.41% | 8,200 -500 | -6% | -$135K |
|
21
Apple
AAPL
$3.45T
| $2.15M | 1.37% | 8,448 +207 | +3% | +$52.6K |
|
|
22
Biogen
BIIB
$19.4B
| $2.14M | 1.37% | 6,760 -1,220 | -15% | -$386K |
|
23
iShares Core Dividend Growth ETF
DGRO
$33.7B
| $2.12M | 1.35% | 64,975 +4,538 | +8% | +$148K |
|
24
Union Pacific
UNP
$133B
| $2.07M | 1.32% | 14,667 -1,650 | -10% | -$233K |
|
25
iShares Russell 1000 ETF
IWB
$43.2B
| $2.04M | 1.3% | 14,396 -40 | -0.3% | -$5.66K |
|